Cannabis in the News, Curaleaf, marijuana stock, Stock Talk, Tilray
3 Oversold Cannabis Stocks with Huge Growth Ahead for 2022 Cannabis stocks have been one of the hardest hit groups in the market in 2022. Many stocks in the group have recently sunk below their pandemic lows recorded in March 2020, while the broad stock market remains...
Cannabis in the News, Cannabis Market, Expansion, Investment Opportunities, Tilray
Poland approves Tilray’s medical cannabis for pharmaceutical distribution Tilray Brands Inc. announced that its medical cannabis division, Tilray Medical, has received approval to commercialize its Tilray branded medical cannabis products in Poland expanding its...
Cannabis in the News, Cannabis Market, marijuana stock, Tilray
Tilray posts $434 million net loss for 2022 Tilray just posted $434 million net loss for its 2022 fiscal year. The net loss includes a $395 million noncash impairment charge “primarily impacting inventory, goodwill and other intangible assets.” On a Thursday...
Aurora Cannabis, Cannabis in the News, Tilray
TSX Struggles, Aurora Cannabis and Tilray Shares Dip The Toronto Stock Exchange or TSX, Canada’s main stock index fell on Wednesday, weighed by weakness in health-care and technology shares amid growing fears that aggressive policy tightening by central banks to...
Aurora Cannabis, Cannabis in the News, Cannabis Market, Cannabis Normalization, Curaleaf, Legalization, Tilray
Legal Cannabis Market Continues Rapid Global Growth The global cannabis market is continuing to grow rapidly thanks to increasing legalization and social adoption across the globe. According to a report by Vantage Market Research, revenue came in at US$12.8 billion in...
Cannabis in the News, Tilray
Tilray Stock falls as cannabis sector shrugs off MORE Act vote NASDAQ:TLRY fell by 3.73% during Friday’s trading session. The MORE Act passes the floor vote in the House of Representatives. Tilray announces its earnings call will be on April 6th, 2022. NASDAQ:TLRY...